Unlike normal prothrombin, which requires vitamin K-dependent carboxylation, PIVKA-II lacks γ-carboxyglutamic acid residues, making it a promising tumor marker in HCC [24]. This evidence concerns the gene F2 and hepatocellular carcinoma.